Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Joaquin Maximiliano Espinosa

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Espinosa, Joaquin

Item TypeName
Concept Trisomy
Concept Down Syndrome
Concept Xenograft Model Antitumor Assays
Academic Article p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer.
Academic Article Multivalent Chromatin Engagement and Inter-domain Crosstalk Regulate MORC3 ATPase.
Grant Mechanisms of gene expression control in the p53 network
Academic Article Exosomal biomarkers in Down syndrome and Alzheimer's disease.
Academic Article Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation.
Academic Article Trisomy 21 Represses Cilia Formation and Function.
Academic Article SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program.
Academic Article Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata.
Grant Understanding Down Syndrome as an Interferonopathy
Academic Article Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors.
Grant JAK Inhibition in Down Syndrome
Academic Article Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.
Academic Article Down Syndrome and COVID-19: A Perfect Storm?
Academic Article Further understanding the connection between Alzheimer's disease and Down syndrome.
Academic Article Tumoural soft tissue calcification in Down syndrome: association with heterozygous germline SAMD9 mutation and hyperactive type I interferon signaling.
Academic Article JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome.
Academic Article Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome.
Academic Article JAK inhibition for treatment of psoriatic arthritis in Down syndrome.
Academic Article Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation.
Academic Article Sonic Hedgehog Pathway Modulation Normalizes Expression of Olig2 in Rostrally Patterned NPCs With Trisomy 21.
Academic Article Trisomy 21 increases microtubules and disrupts centriolar satellite localization.
Academic Article IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome.
Academic Article Enhanced T cell effector activity by targeting the Mediator kinase module.
Academic Article Cardiopulmonary Phenotypes and Protein Signatures in Children With Down Syndrome.
Academic Article Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition.
Academic Article Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling.
Academic Article Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model.
Academic Article Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome.
Academic Article Down syndrome is associated with altered frequency and functioning of tracheal multiciliated cells, and response to influenza virus infection.
Grant Trisomy 21 Model Atlas
Grant Mechanistic investigation of therapies for Down Syndrome Regression Disorder
Grant Data Science for Diverse Scholars in Down Syndrome Research (DS3)
Grant Multidimensional investigation of auditory dysfunction in Down syndrome
Grant JAK Inhibition in Down Syndrome

Search Criteria
  • Trisomy
  • X
  • Syndrome

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)